CEO for LipidEra Therapeutics wanted!

Does revolutionising healthcare and saving lives sound interesting to you? You might be the perfect fit to become a CEO of LipidEra. This position is now opened by our partnering company NLC Health Ventures.


About LipidEra

Despite available therapies, many patients still struggle to meet their cholesterol targets, leaving them at high risk for heart attacks and strokes. LipidEra Therapeutics is changing this narrative with LipidEra-01, a groundbreaking solution designed to effectively lower cholesterol levels and reduce the risk of cardiovascular diseases.

About the invention:
The research team from Charles University and IOCB Prague has developed a groundbreaking small molecule with a novel dual mechanism of action, poised to lower LDL cholesterol in statin-intolerant heterozygous hypercholesterolemia patients and address other related metabolic disorders. This affordable and innovative solution has already demonstrated outstanding results in animal studies. We are seeking a visionary entrepreneur to lead the charge and bring this promising treatment to market.

The Opportunity:
As the CEO of LipidEra, you will spearhead our efforts to bring LipidEra-01 to market and make a profound impact on global health. You’ll have the opportunity to lead a passionate team, drive innovation, and shape the future of cholesterol treatment.

-Provide strategic leadership to advance LipidEra’s mission and vision, and oversee the development and commercialization of LipidEra-01.
-Build and nurture relationships with key stakeholders, including investors, partners, and regulatory agencies.
-Lead fundraising efforts to support clinical development and company growth.
-Cultivate a culture of excellence, collaboration, and innovation within the organisation.

-Proven leadership experience in the biopharmaceutical industry, preferably in cardiovascular or lipid management.
-Demonstrated track record of successful fundraising and business development.
-Excellent communication and interpersonal skills.
-Visionary mindset with a passion for improving patient outcomes.

Last but not least

As a CEO for LipidEra Therapeutics, you will have the unique opportunity to lead the charge in bringing a groundbreaking small molecule treatment to market, offering a superior second-line solution for statin-resistant patients, and making a significant impact on the health and well-being of countless individuals and society as a whole.

Apply for the job:

More to read

Safe-to-touch fire blankets

PRESS RELEASE Foga blankets can replace fire extinguishers in many businesses and homes, a technology developed by scientists at Charles University Prague, April 10, 2024 – Charles University, on behalf of its subsidiary Charles University Innovations Prague, Inc. (CUIP) and the…

Establishment of the Czech-Algerian Partnership

The leading Czech transfer company Charles University Innovations Prague a.s. (CUIP) welcomed an Algerian delegation headed by the Minister of Knowledge Economy and Start-ups, Yacine El-Mahdi Oualid, to its offices on Tuesday 9 May. Establishing cooperation within the Twinning framework,…